A case of coexistence of hydroa vacciniforme-like lymphoproliferative disorder and Epstein-Barr virus pneumonia
| Published in: | JAAD Case Reports |
|---|---|
| Main Authors: | Wei Zhang, MD, PhD, Weixia Xuan, MD, Shuping Wu, BS, Yuhui Shi, BS, Yan Li, BS |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-09-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512625002681 |
Similar Items
Hydroa vacciniforme lymphoproliferative disorder:a case report
by: ZHU Xia, JIN Jingjing, WANG Xin, MIAO Fei, MA Jiexian, ZHANG Jiechen, XIAO Li
Published: (2023-12-01)
by: ZHU Xia, JIN Jingjing, WANG Xin, MIAO Fei, MA Jiexian, ZHANG Jiechen, XIAO Li
Published: (2023-12-01)
Two cases of hydroa vacciniforme lymphoproliferative disorder in elderly patients: Excellent response to narrow-band ultraviolet B phototherapy
by: Ozumi Tomita, MD, et al.
Published: (2025-01-01)
by: Ozumi Tomita, MD, et al.
Published: (2025-01-01)
Hemophagocytic lymphohistiocytosis syndrome secondary to systemic hydroa vacciniforme lymphoproliferative disorder: a case report and literature review
by: Sai YANG, et al.
Published: (2024-02-01)
by: Sai YANG, et al.
Published: (2024-02-01)
Hydroa vacciniforme
by: Sandra Helena Yepes R., et al.
Published: (2002-02-01)
by: Sandra Helena Yepes R., et al.
Published: (2002-02-01)
Hydroa vacciniforme-like lymphoma: a case report and literature review
by: Hung-Chien Lin, et al.
Published: (2010-12-01)
by: Hung-Chien Lin, et al.
Published: (2010-12-01)
Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases
by: Na Guo, et al.
Published: (2019-07-01)
by: Na Guo, et al.
Published: (2019-07-01)
Extensive hydroa vacciniforme
by: Hiram Larangeira de Almeida Jr, et al.
Published: (2013-08-01)
by: Hiram Larangeira de Almeida Jr, et al.
Published: (2013-08-01)
Refractory Hydroa Vacciniforme-Like Lymphoma: Biological Insights from Morphoproteomic Analysis
by: Rohit Goswamy, et al.
Published: (2022-07-01)
by: Rohit Goswamy, et al.
Published: (2022-07-01)
Case Report: Hydroa vacciniforme-like lymphoproliferative disorder, an EBV-associated disease, successfully treated with hematopoietic stem cell transplantation
by: Eduardo Liquidano-Perez, et al.
Published: (2025-03-01)
by: Eduardo Liquidano-Perez, et al.
Published: (2025-03-01)
GATA2 Deficiency and Epstein–Barr Virus Disease
by: Jeffrey I. Cohen
Published: (2017-12-01)
by: Jeffrey I. Cohen
Published: (2017-12-01)
Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
by: Shigeyoshi Fujiwara, et al.
Published: (2019-07-01)
by: Shigeyoshi Fujiwara, et al.
Published: (2019-07-01)
Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
by: James P. Dugan, et al.
Published: (2019-03-01)
by: James P. Dugan, et al.
Published: (2019-03-01)
Quantitative Analysis of Epstein-Barr Virus DNA Load in Bone Marrow Transplant Recipients By Using Real-Time PCR
by: Sabri SH., et al.
Published: (2005-09-01)
by: Sabri SH., et al.
Published: (2005-09-01)
Quantitative Analysis of Epstein-Barr Virus DNA Load in Bone Marrow Transplant Recipients By Using Real-Time PCR
by: SH Sabri, et al.
Published: (2005-09-01)
by: SH Sabri, et al.
Published: (2005-09-01)
X‐linked lymphoproliferative syndrome associated with Epstein–Barr virus encephalitis and lymphoproliferative disorder
by: Takeo Mukai, et al.
Published: (2023-09-01)
by: Takeo Mukai, et al.
Published: (2023-09-01)
Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders
by: Xi Yang, et al.
Published: (2015-10-01)
by: Xi Yang, et al.
Published: (2015-10-01)
Systemic Epstein–Barr Virus-Positive T/NK Lymphoproliferative Diseases With SH2D1A/XIAP Hypomorphic Gene Variants
by: Masataka Ishimura, et al.
Published: (2019-05-01)
by: Masataka Ishimura, et al.
Published: (2019-05-01)
Case of primary intraocular lymphoproliferative disorder caused by Epstein–Barr Virus
by: Yumiko Ban, et al.
Published: (2020-07-01)
by: Yumiko Ban, et al.
Published: (2020-07-01)
Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
by: Junhong Ai, et al.
Published: (2018-10-01)
by: Junhong Ai, et al.
Published: (2018-10-01)
Adoptive Cell Immunotherapy in Relapse/Refractory Epstein–Barr Virus-Driven Post-Transplant Lymphoproliferative Disorders
by: Martina Canichella, et al.
Published: (2025-06-01)
by: Martina Canichella, et al.
Published: (2025-06-01)
Clinical characteristics and literature review of chronic active Epstein–Barr virus‐associated enteritis
by: Yajie Meng, et al.
Published: (2024-06-01)
by: Yajie Meng, et al.
Published: (2024-06-01)
Epstein–Barr Virus Detection in Lymphoproliferative Disorders: Epidemiological Characterization in Western Mexico
by: Karel Cesar Licona-Lasteros, et al.
Published: (2025-08-01)
by: Karel Cesar Licona-Lasteros, et al.
Published: (2025-08-01)
Inherited Immunodeficiencies With High Predisposition to Epstein–Barr Virus-Driven Lymphoproliferative Diseases
by: Sylvain Latour, et al.
Published: (2018-06-01)
by: Sylvain Latour, et al.
Published: (2018-06-01)
Central Nervous System Involvement of Epstein Barr Virus Associated Lymphoproliferative Disorder in a Child with Acute Lymphoblastic Leukemia: Successful Treatment with Rituximab and Interferon-Alpha
by: Berna Atabay, et al.
Published: (2013-03-01)
by: Berna Atabay, et al.
Published: (2013-03-01)
Analysis of risk factors for Epstein–Barr virus reactivation and progression to post-transplant lymphoproliferative disorder in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation
by: Lanzhou Jia, et al.
Published: (2025-07-01)
by: Lanzhou Jia, et al.
Published: (2025-07-01)
Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
by: Jennifer L. Crombie, et al.
Published: (2019-03-01)
by: Jennifer L. Crombie, et al.
Published: (2019-03-01)
Case report: Cellular therapy for hydroa vacciniforme-like lymphoproliferative disorder in pediatric common variable immunodeficiency with chronic active Epstein-Barr virus infection
by: Elżbieta Grześk, et al.
Published: (2022-08-01)
by: Elżbieta Grześk, et al.
Published: (2022-08-01)
Epstein-Barr virus-related lymphoproliferative disorders of the skin
by: Gerardo Ferrara, et al.
Published: (2024-05-01)
by: Gerardo Ferrara, et al.
Published: (2024-05-01)
EBV-Associated Lymphoproliferative Disorders
by: Young Hyeh Ko
Published: (2021-04-01)
by: Young Hyeh Ko
Published: (2021-04-01)
Chylous abdomen with Epstein-Barr virus-associated T Lymphoproliferative diseases in children: A case report
by: Jie Liu, et al.
Published: (2023-11-01)
by: Jie Liu, et al.
Published: (2023-11-01)
Hidroa vacciniforme y el desorden linfoproliferativo hidroa vacciniforme-like reporte de caso y revisión de la literatura
by: Ana María Gutiérrez-Delgadillo, et al.
Published: (2024-07-01)
by: Ana María Gutiérrez-Delgadillo, et al.
Published: (2024-07-01)
Epstein–Barr Virus and Innate Immunity: Friends or Foes?
by: Sonia Jangra, et al.
Published: (2019-06-01)
by: Sonia Jangra, et al.
Published: (2019-06-01)
Clinical epidemiology of Epstein-Barr virus-associated Lymphoproliferative Disorders (EBV-LPDs) in hospitalized children: A six-year multi-institutional study in China
by: Dilara Dilmurat, et al.
Published: (2024-07-01)
by: Dilara Dilmurat, et al.
Published: (2024-07-01)
Sintilimab treatment for chronic active Epstein–Barr virus infection and Epstein–Barr virus-associated hemophagocytic lymphohistiocytosis in children
by: Ruyue Chen, et al.
Published: (2023-09-01)
by: Ruyue Chen, et al.
Published: (2023-09-01)
Hidroa vacciniforme
by: Silvia Emelia Herrera Higuita
Published: (2003-12-01)
by: Silvia Emelia Herrera Higuita
Published: (2003-12-01)
Epstein-Barr virus reactivation and disease flare of systemic lupus erythematosus
by: Chung-Jen Chen
Published: (2024-03-01)
by: Chung-Jen Chen
Published: (2024-03-01)
Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
by: Sanjay de Mel, et al.
Published: (2019-01-01)
by: Sanjay de Mel, et al.
Published: (2019-01-01)
Factors Associated with Post-Transplant Active Epstein-Barr Virus Infection and Lymphoproliferative Disease in Hematopoietic Stem Cell Transplant Recipients: A Systematic Review and Meta-Analysis
by: Pascal Roland Enok Bonong, et al.
Published: (2021-03-01)
by: Pascal Roland Enok Bonong, et al.
Published: (2021-03-01)
Case Report: Non-negligible Epstein-Barr virus-associated posttransplant lymphoproliferative disorders in a lung transplant recipient
by: Juan Hu, et al.
Published: (2023-09-01)
by: Juan Hu, et al.
Published: (2023-09-01)
A mild, self-resolving case of Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis
by: Biplov Adhikari, et al.
Published: (2022-01-01)
by: Biplov Adhikari, et al.
Published: (2022-01-01)
Similar Items
-
Hydroa vacciniforme lymphoproliferative disorder:a case report
by: ZHU Xia, JIN Jingjing, WANG Xin, MIAO Fei, MA Jiexian, ZHANG Jiechen, XIAO Li
Published: (2023-12-01) -
Two cases of hydroa vacciniforme lymphoproliferative disorder in elderly patients: Excellent response to narrow-band ultraviolet B phototherapy
by: Ozumi Tomita, MD, et al.
Published: (2025-01-01) -
Hemophagocytic lymphohistiocytosis syndrome secondary to systemic hydroa vacciniforme lymphoproliferative disorder: a case report and literature review
by: Sai YANG, et al.
Published: (2024-02-01) -
Hydroa vacciniforme
by: Sandra Helena Yepes R., et al.
Published: (2002-02-01) -
Hydroa vacciniforme-like lymphoma: a case report and literature review
by: Hung-Chien Lin, et al.
Published: (2010-12-01)
